Back
Day Range
$10.33
$10.80
52-Week Range
$2.60
$11.23
Volume
179,836
50D / 200D Avg
$10.15
/
$7.17
Prev Close
$10.71
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (633 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -9.3 | 0.2 |
| P/B | 3.1 | 2.8 |
| ROE % | -30.7 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$15.67
+48.8%
Low: $14.00
High: $18.00
Forward EPS
-$1.36
Est. Revenue
117.33M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.41
-$0.41 – -$0.41
|
224.42M | 2 |
| FY2029 |
-$1.61
-$1.61 – -$1.61
|
69.26M | 2 |
| FY2028 |
-$2.01
-$2.38 – -$1.61
|
8.50M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-09 | -$0.38 | -$0.28 | +26.6% |
| 2025-11-05 | -$0.34 | -$0.30 | +11.8% |
| 2025-08-07 | -$0.32 | -$0.34 | -6.3% |
| 2025-05-07 | -$0.28 | -$0.31 | -10.7% |
| 2025-03-10 | -$0.28 | -$0.24 | +14.3% |
| 2024-11-07 | -$0.26 | -$0.23 | +11.5% |
| 2024-08-05 | -$0.25 | -$0.21 | +16.0% |
| 2024-05-08 | -$0.28 | -$0.20 | +28.6% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -54.55M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-30.70%
ROIC-27.96%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio17.14
Interest Coverage0.00
Valuation
P/E Ratio
-9.30
Forward P/EN/A
P/B Ratio3.06
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -69.79M |
| ROE | -30.70% | ROA | -30.85% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -54.55M |
| ROIC | -27.96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 17.14 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9.30 | Forward P/E | N/A |
| P/B Ratio | 3.06 | P/S Ratio | N/A |
| PEG Ratio | -0.20 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 5.53 | Fwd Earnings Yield | N/A |
| FCF Yield | -8.40% | ||
| Market Cap | 649.41M | Enterprise Value | 633.20M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -69.79M | -49.59M | -66.86M | -63.31M | -35.53M |
| EPS (Diluted) | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 |
| Gross Profit | -622,000.0 | -596,000.0 | -537,000.0 | -466,000.0 | 0.0 |
| Operating Income | -79.47M | -62.38M | -78.19M | -67.59M | -35.83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 226.20M | 252.09M | 289.64M | 341.14M | 390.56M |
| Total Liabilities | 13.70M | 10.00M | 11.96M | 13.83M | 8.43M |
| Shareholders' Equity | 212.50M | 242.10M | 277.69M | 327.31M | 382.13M |
| Total Debt | 645,000.0 | 2.33M | 3.05M | 3.69M | 3.63M |
| Cash & Equivalents | 16.86M | 22.56M | 21.20M | 26.50M | 298.57M |
| Current Assets | 223.78M | 248.04M | 284.58M | 335.12M | 385.44M |
| Current Liabilities | 13.06M | 8.46M | 9.62M | 10.78M | 5.28M |